At a glance
ClinicalIndex Comparison RecordN/ACompleted· 78 enrolled
Drug / intervention
Hybrid Closed Loopdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In-Clinic Feasibility Study to Observe the Overnight Closed Loop System
In Brief
A clinical study evaluating Hybrid Closed Loop for Type 1 Diabetes. Completed, enrolled 78 participants across 6 sites.
Detailed Summary
This is a multicenter feasibility study. Up to 85 subjects will be enrolled in the study. The goal of the study is to demonstrate that the Hybrid Closed Loop (HCL) System is safe to be used in an even larger study outside of hospital.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 2013
Enrollment StartJun 2013
Primary CompletionJun 2016
Study CompletionOct 2016
TodayJul 2026
First PostedMay 20, 2013
Enrollment StartJun 1, 2013
Primary CompletionJun 1, 2016
Study CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 13.1 years ago
Interventions
Hybrid Closed Loopdevice
The Hybrid Closed Loop System is an investigational device intended for closed loop control of blood glucose.